Co-Diagnostics Inc Announces Positive Results from Co-Primers™ Technology in Multiplex Tests for SNP Detection

SALT LAKE CITY (BUSINESS WIRE) Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that ongoing research and development activities of the Company’s Co-Primer™ platform technology has yielded positive results in demonstrating the capabilities of Co-Primers in multiplex tests for SNP detection. The Company will utilize its proprietary design software and patent-pending Co-Primer technology to provide molecular testing solutions for use by customers. These include enterprise The post Co-Diagnostics Inc Announces Positive Results from Co-Primers™ Technology in Multiplex Tests for SNP Detection appeared first on Public Wire.
http://bit.ly/2t2C5Yz